These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 32877570
1. The factor VIII treatment history of non-severe hemophilia A. Abdi A, Kloosterman FR, Eckhardt CL, Male C, Castaman G, Fischer K, Beckers EAM, Kruip MJHA, Peerlinck K, Mancuso ME, Santoro C, Hay CR, Platokouki H, van der Bom JG, Gouw SC, Fijnvandraat K, Hart DP, INSIGHT Study Group. J Thromb Haemost; 2020 Dec; 18(12):3203-3210. PubMed ID: 32877570 [Abstract] [Full Text] [Related]
2. Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A. Agosti P, Siboni SM, Scardo S, Torri A, Gualtierotti R, Peyvandi F. Blood Adv; 2023 Dec 12; 7(23):7209-7215. PubMed ID: 37871302 [Abstract] [Full Text] [Related]
3. The bleeding phenotype in people with nonsevere hemophilia. Kloosterman FR, Zwagemaker AF, Bagot CN, Beckers EAM, Castaman G, Cnossen MH, Collins PW, Hay C, Hof M, Laros-van Gorkom B, Leebeek FWG, Male C, Meijer K, Pabinger I, Shapiro S, Coppens M, Fijnvandraat K, Gouw SC. Blood Adv; 2022 Jul 26; 6(14):4256-4265. PubMed ID: 35533261 [Abstract] [Full Text] [Related]
9. Bleeding phenotype according to factor level in 825 children with nonsevere hemophilia: data from the PedNet cohort. de Kovel MS, Escuriola-Ettingshausen C, Königs C, Ranta S, Fischer K, PedNet Study Group. J Thromb Haemost; 2024 Sep 26; 22(9):2460-2469. PubMed ID: 38866249 [Abstract] [Full Text] [Related]
12. Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting. Ay C, Perschy L, Rejtö J, Kaider A, Pabinger I. Ann Hematol; 2020 Dec 26; 99(12):2763-2771. PubMed ID: 32918114 [Abstract] [Full Text] [Related]
14. Joint status of patients with nonsevere hemophilia A. Zwagemaker AF, Kloosterman FR, Hemke R, Gouw SC, Coppens M, Romano LGR, Kruip MJHA, Cnossen MH, Leebeek FWG, Hutten BA, Maas M, Fijnvandraat K. J Thromb Haemost; 2022 May 26; 20(5):1126-1137. PubMed ID: 35171522 [Abstract] [Full Text] [Related]
17. Perioperative continuous infusions of factor VIII versus factor IX for patients with hemophilia A or B undergoing major surgery. Tse B, Nisenbaum R, Floros G, Jiwajee A, Teitel J, Sholzberg M. J Thromb Thrombolysis; 2023 Feb 26; 55(2):273-281. PubMed ID: 36547766 [Abstract] [Full Text] [Related]
19. Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non-interventional study in a real-world setting. Kruse-Jarres R, Oldenburg J, Santagostino E, Shima M, Kempton CL, Kessler CM, Lehle M, Chebon S, Selak Bienz N, Asikanius E, Mahlangu J. Haemophilia; 2019 Mar 26; 25(2):213-220. PubMed ID: 30724422 [Abstract] [Full Text] [Related]
20. Association between Sports Participation, Factor VIII Levels and Bleeding in Hemophilia A. Bukkems LH, Versloot O, Cnossen MH, Jönsson S, Karlsson MO, Mathôt RAA, Fischer K. Thromb Haemost; 2023 Mar 26; 123(3):317-325. PubMed ID: 36402130 [Abstract] [Full Text] [Related] Page: [Next] [New Search]